Results 1 to 10 of about 299,964 (312)

The feasibility of modified HIV and antiretroviral drug testing using self-collected dried blood spots from men who have sex with men

BMC Infectious Diseases, 2021
Background In the US, one in six men who have sex with men (MSM) with HIV are unaware of their HIV infection. In certain circumstances, access to HIV testing and viral load (VL) monitoring is challenging.
Wei Luo, Vickie Sullivan, Pollyanna R. Chavez, Sarah E. Wiatrek, Maria Zlotorzynska, Amy Martin, Rebecca Rossetti, Travis Sanchez, Patrick Sullivan, Robin J. MacGowan, S. Michele Owen, Silvina Masciotra   +11 more
doaj   +1 more source

E-Cigarette Use Among Persons With Diagnosed HIV in the U.S.

AJPM Focus, 2023
Introduction: E-cigarettes emerged in the U.S. market in the late 2000s. In 2017, E-cigarette use among U.S. adults was 2.8%, with higher use among some population groups.
Stacy L. Thorne, PhD, MPH, Ralph S. Caraballo, PhD, Yunfeng Tie, PhD, Norma S. Harris, PhD, R. Luke Shouse, MD, MPH, John T. Brooks, MD   +5 more
doaj   +1 more source

HIV treatment for prevention [PDF]

Journal of the International AIDS Society, 2011
“No virus, no transmission.” Studies have repeatedly shown that viral load (the quantity of virus present in blood and sexual secretions) is the strongest predictor of HIV transmission during unprotected sex or transmission from infected mother to child.Effective treatment lowers viral load to undetectable levels.
Ambrosioni Czyrko, Juan, Calmy, Alexandra, Hirschel, Bernard   +2 more
openaire   +4 more sources

Condoms and prevention of HIV [PDF]

BMJ, 2004
Promotion of condoms has been a mainstay of HIV prevention policy. Over the past few years, however, the value and effectiveness of condoms have increasingly been called into question. The growing “abstinence only” movement in the United States questions the provision of condoms as part of the policy and messaging of the US Agency for International ...
Foss, Anna M, Watts, Charlotte H, Vickerman, Peter, Heise, Lori   +3 more
openaire   +3 more sources

Pharmacokinetics and efficacy of topical inserts containing tenofovir alafenamide fumarate and elvitegravir administered rectally in macaquesResearch in context

EBioMedicine, 2022
Summary: Background: Topical on-demand forms for HIV pre-exposure prophylaxis (PrEP) may be a desirable alternative for people that prefer not to use daily PrEP.
Natalia Makarova, Tyana Singletary, M. Melissa Peet, James Mitchell, Angela Holder, Chuong Dinh, Vivek Agrahari, Maria Mendoza, Yi Pan, Walid Heneine, Meredith R. Clark, J. Gerardo García-Lerma, James M. Smith, Gustavo F. Doncel   +13 more
doaj   +1 more source

HIV-1 subtype diversity and transmission strain source among men who have sex with men in Guangxi, China

Scientific Reports, 2021
With the rapid increase in HIV prevalence of men who have sex with men (MSM) in recent years and common human migration and travelling across different provinces in China, MSM are now finding it easier to meet each other, which might contribute to local ...
Yi Chen, Zhiyong Shen, Yi Feng, Yuhua Ruan, Jianjun Li, Shuai Tang, Kailing Tang, Shujia Liang, Xianwu Pang, Edward B. McNeil, Hui Xing, Virasakdi Chongsuvivatwong, Mei Lin, Guanghua Lan   +13 more
doaj   +1 more source

Effectively Addressing Human Immunodeficiency Virus Disparities Affecting US Black Women

Health Equity, 2018
Black women have disproportionately higher rates of human immunodeficiency virus (HIV) infection, and low percentages being linked to care and becoming virally suppressed, compared with women of other races/ethnicities.
Erin L.P. Bradley, Angelica Geter, Ashley C. Lima, Madeline Y. Sutton, Donna Hubbard McCree   +4 more
doaj   +1 more source

HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making.

PLoS Medicine, 2012
Antiretroviral therapy (ART) for those infected with HIV can prevent onward transmission of infection, but biological efficacy alone is not enough to guide policy decisions about the role of ART in reducing HIV incidence.
HIV Modelling Consortium Treatment as Prevention Editorial Writing Group
doaj   +1 more source

Long-term immunological responses to treatment among HIV-2 patients in Côte d’Ivoire

BMC Infectious Diseases, 2020
Background Studies indicate that responses to HIV-2 treatment regimens are worse than responses to HIV-1 regimens during the first 12 months of treatment, but longer-term treatment responses are poorly described.
Peter A. Minchella, Christiane Adjé-Touré, Guoqing Zhang, Andre Tehe, Judith Hedje, Erin R. Rottinghaus, Natacha Kohemun, Micheline Aka, Karidia Diallo, G. Laissa Ouedraogo, Kevin M. De Cock, John N Nkengasong   +11 more
doaj   +1 more source

Awareness of and willingness to use oral pre-exposure prophylaxis (PrEP) for HIV prevention among sexually active adults in Malawi: results from the 2020 Malawi population-based HIV impact assessment

BMC Infectious Diseases, 2023
Background The World Health Organization recommends Pre-Exposure Prophylaxis (PrEP) for all populations at substantial risk of HIV infection. Understanding PrEP awareness and interest is crucial for designing PrEP programs; however, data are lacking in ...
Alinune Nathanael Kabaghe, Victor Singano, Danielle Payne, Alice Maida, Rose Nyirenda, Kelsey Mirkovic, Andreas Jahn, Pragna Patel, Kristin Brown, Mansoor Farahani, Felix Kayigamba, Lyson Tenthani, Francis Ogollah, Andrew Auld, Fatima Zulu, Wezi Msungama, Nellie Wadonda-Kabondo   +16 more
doaj   +1 more source